Elanco Animal Health Inc. (NASDAQ: ELAN) stock gained by 0.9% at last close whereas the ELAN stock price plunged by 5.3% at last check during the after-hour session. Elanco Animal Health is a world leader in animal health devoted to developing and providing goods and services that help farmers, pet owners, veterinarians, stakeholders, and society as a whole prevent and manage illness in farm animals and pets.
Jeff Simmons, president, and CEO will take part in a roundtable discussion at the Stifel 2021 Virtual Jaws & Paws Conference on Thursday, June 3. The conversation will start at 2:30 p.m. Eastern Time and will last about 25 minutes.
Jeff Simmons will also take part in a fireside talk at the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10. The panel will begin at 9:40 a.m. Eastern Time and will last about 40 minutes.
These meetings will take place over the internet.
Recent Past Development
In the United States, Elanco Animal Health introduces ZoaShield, a validated and versatile zoalene solution that holds coccidiosis under control in a simple, manageable manner. Having a stable, effective anticoccidial program is essential for maintaining optimal bird health, particularly in No Antibiotics Ever (NAE) flocks. ZoaShield provides growers with a versatile, tried-and-true active ingredient that can be used in a number of seasons and operations.
Andrew Carlson, executive director of U.S. Poultry and Nutritional Health at Elanco said,
As an anticoccidial, producers are familiar with and trust zoalene. Producers have come to expect ZoaShield to help them control coccidiosis in their flocks, and it does so while still offering flexibility for their service.
Elanco field consultants with deep business expertise and understanding provide consultative assistance to farmers who use ZoaShield or either of the Elanco intestinal integrity products. This allows them to customize solutions to all forms of poultry operations.